175 related articles for article (PubMed ID: 34741494)
1. Intrapleural treatment in patients with non-small cell lung cancer with malignant pleural effusions in the real world.
Pan P; Wu F; Xu Z; Ji X; Qi Q; Huang X; Zhao R; Liu M; Jiang P; Li Y; Xu L
Thorac Cancer; 2021 Dec; 12(24):3416-3425. PubMed ID: 34741494
[TBL] [Abstract][Full Text] [Related]
2. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
3. Intrapleural combination therapy with bevacizumab and cisplatin for non-small cell lung cancer‑mediated malignant pleural effusion.
Du N; Li X; Li F; Zhao H; Fan Z; Ma J; Fu Y; Kang H
Oncol Rep; 2013 Jun; 29(6):2332-40. PubMed ID: 23525453
[TBL] [Abstract][Full Text] [Related]
4. Combined intrapleural and intravenous chemotherapy, and pulmonary irradiation, for treatment of patients with lung cancer presenting with malignant pleural effusion. A pilot study.
Su WC; Lai WW; Chen HH; Hsiue TR; Chen CW; Huang WT; Chen TY; Tsao CJ; Wang NS
Oncology; 2003; 64(1):18-24. PubMed ID: 12457027
[TBL] [Abstract][Full Text] [Related]
5. Bevacizumab plus chemotherapy in nonsquamous non-small cell lung cancer patients with malignant pleural effusion uncontrolled by tube drainage or pleurodesis: A phase II study North East Japan Study group trial NEJ013B.
Noro R; Kobayashi K; Usuki J; Yomota M; Nishitsuji M; Shimokawa T; Ando M; Hino M; Hagiwara K; Miyanaga A; Seike M; Kubota K; Gemma A;
Thorac Cancer; 2020 Jul; 11(7):1876-1884. PubMed ID: 32421226
[TBL] [Abstract][Full Text] [Related]
6. A randomized clinical study to compare intrapleural infusion with intravenous infusion of bevacizumab in the management of malignant pleural effusion in patients with non-small-cell lung cancer.
Nie K; Zhang Z; You Y; Zhuang X; Zhang C; Ji Y
Thorac Cancer; 2020 Jan; 11(1):8-14. PubMed ID: 31726490
[TBL] [Abstract][Full Text] [Related]
7. Intrapleural administration of cisplatin and etoposide to treat malignant pleural effusions in patients with non-small cell lung cancer.
Tohda Y; Iwanaga T; Takada M; Yana T; Kawahara M; Negoro S; Okishio K; Kudoh S; Fukuoka M; Furuse K
Chemotherapy; 1999; 45(3):197-204. PubMed ID: 10224342
[TBL] [Abstract][Full Text] [Related]
8. Intrapleural combination therapy with lobaplatin and erythromycin for non-small cell lung cancer-mediated malignant pleural effusion.
Xu L; Wang B; Gao M; Zhang Y; Qi Q; Li T; Li C; Wang A; Li Y
Thorac Cancer; 2018 Aug; 9(8):950-955. PubMed ID: 29917319
[TBL] [Abstract][Full Text] [Related]
9. Superiority and clinical significance of Lunx mRNA in the diagnosis of malignant pleural effusion caused by pulmonary carcinoma.
Tang Y; Xu L
J Exp Clin Cancer Res; 2013 Jun; 32(1):37. PubMed ID: 23759037
[TBL] [Abstract][Full Text] [Related]
10. Previous Radiotherapy Increases the Efficacy of IL-2 in Malignant Pleural Effusion: Potential Evidence of a Radio-Memory Effect?
Chen D; Song X; Wang H; Gao Z; Meng W; Chen S; Ma Y; Wang Y; Li K; Yu J; Yue J
Front Immunol; 2018; 9():2916. PubMed ID: 30619280
[TBL] [Abstract][Full Text] [Related]
11. Does cytoreduction surgery and hyperthermic intrathoracic chemotherapy prolong survival in patients with N0-N1 nonsmall cell lung cancer and malignant pleural effusion?
Migliore M; Nardini M
Eur Respir Rev; 2019 Sep; 28(153):. PubMed ID: 31366459
[TBL] [Abstract][Full Text] [Related]
12. [Impact of intrapleural hyperthermic perfusion on immunologic reaction state of cytokines TH1/TH2 of lung carcinoma patients with malignant pleural effusion].
Kang MQ; Cao YP; Deng F
Ai Zheng; 2008 Feb; 27(2):210-3. PubMed ID: 18279624
[TBL] [Abstract][Full Text] [Related]
13. Radiofrequency deep hyperthermia combined with chemotherapy in the treatment of advanced non-small cell lung cancer.
Yang WH; Xie J; Lai ZY; Yang MD; Zhang GH; Li Y; Mu JB; Xu J
Chin Med J (Engl); 2019 Apr; 132(8):922-927. PubMed ID: 30958433
[TBL] [Abstract][Full Text] [Related]
14. Intracavitary chemotherapy with epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) is not superior to TKI monotherapy in controlling malignant pleural effusion recurrence in
Wang W; Jiang X; Zhang Y; Song Y; Song Z
J Thorac Dis; 2019 Sep; 11(9):3712-3720. PubMed ID: 31656643
[TBL] [Abstract][Full Text] [Related]
15. Better effect of intrapleural perfusion with hyperthermic chemotherapy by video-assisted thoracoscopic surgery for malignant pleural effusion treatment compared to normothermic chemoperfusion of the pleural cavity.
Cao Y; Zhang Q; Huang Z; Chai Z; Liu J; Wang J; Sun Z; Zhao T; Wang G; Chen G; Han Y; Li Q; Hong X
Cancer Med; 2022 Jan; 11(2):348-357. PubMed ID: 34854253
[TBL] [Abstract][Full Text] [Related]
16. Intrapleural cisplatin and OK432 therapy for malignant pleural effusion caused by non-small cell lung cancer.
Ishida A; Miyazawa T; Miyazu Y; Iwamoto Y; Zaima M; Kanoh K; Sumiyoshi H; Doi M
Respirology; 2006 Jan; 11(1):90-7. PubMed ID: 16423208
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of intrapleural paclitaxel injection for non-small-cell lung cancer patients with malignant pleural effusions.
Perng RP; Chen YM; Wu MF; Chou KC; Lin WC; Liu JM; Whang-Peng J
Respir Med; 1998 Mar; 92(3):473-9. PubMed ID: 9692108
[TBL] [Abstract][Full Text] [Related]
18. Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot study.
Choi MG; Park S; Oh DK; Kim HR; Lee GD; Lee JC; Choi CM; Ji W
Thorac Cancer; 2019 Oct; 10(10):1885-1892. PubMed ID: 31389192
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of pleural effusion caused by lung carcinoma with circular intrapleural hyperthermic perfusion and its mechanism].
Kang M; Zhou L; Lin P
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1176-9. PubMed ID: 11769704
[TBL] [Abstract][Full Text] [Related]
20. Intrapleural Injection of Anti-PD1 Antibody: A Novel Management of Malignant Pleural Effusion.
Li X; Wu G; Chen C; Zhao Y; Zhu S; Song X; Yin J; Lv T; Song Y
Front Immunol; 2021; 12():760683. PubMed ID: 34966384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]